For subscribers
Moderna ready to invest in S’pore as it seeks to raise Asia-Pac headcount to 200 by end-2023
Sign up now: Get ST's newsletters delivered to your inbox
Moderna is looking for a location for its Singapore subsidiary.
PHOTO: REUTERS
Follow topic:
SINGAPORE - Biotechnology firm Moderna has committed to investing in Singapore and the region, with plans to grow its Asia-Pacific headcount from 80 to 200 by the end of 2023.
On Monday, the American company announced its new Singapore general manager, Ms Evelyn Pang, who will head and grow its Singapore office. She will be setting up a team to oversee a range of functions to support commercial and medical activities in the market.
